Form 8-K - Current report:
SEC Accession No. 0000950170-25-040230
Filing Date
2025-03-17
Accepted
2025-03-17 16:05:09
Documents
12
Period of Report
2025-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enta-20250313.htm   iXBRL 8-K 93114
2 EX-10.1 enta-ex10_1.htm EX-10.1 152385
  Complete submission text file 0000950170-25-040230.txt   384812

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT enta-20250313.xsd EX-101.SCH 25023
14 EXTRACTED XBRL INSTANCE DOCUMENT enta-20250313_htm.xml XML 4757
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 25744371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)